אבוגן בע"מ

The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Castera Ltd.

Life sciences, Human health and Agriculture industry.

Ofer Haviv - CEO & President

Mark Kapel - EVP, Technology / CTO

Yaron Eldad - CFO